Health Economics and Reimbursement Summary of PROPOSED 2015 Medicare Hospital Outpatient, Ambulatory Surgical Center and Physician Payment Rates Interventional Cardiology Peripheral Interventions Rhythm Management On July 3, 2014, the Centers for Medicare and Medicaid Services (CMS) released the Calendar Year (CY)2015 proposed policies and payment rates for Medicare’s Outpatient Prospective Payment System (OPPS) and Ambulatory Surgical Centers (ASC). CMS also released the CY 2015 proposed rule and payment rates for the Physician Fee Schedule (PFS). As is customary, CMS provides the public the ability to comment on proposed changes prior to finalizing their decisions in the Final Rules. The final policy and payment rate are expected about November 1, 2014, and are effective on January 1, 2015. Hospital Outpatient: Average rates for outpatient services would increase by 2.1% in 2015 for more than 4,000 hospitals that participate in Medicare. Ambulatory Surgical Center: Overall ASC payments are proposed to increase is 1.2%, over CY 2014 rates. Approximately 5,300 ASC’s participate in Medicare and are paid under the ASC payment system. Physician Fee Schedule: As a result of the recent Sustainable Growth Rate (SGR) patch passed earlier this year, the current conversion factor of $35.8228 is effective through March 31, 2015. The proposed rates reflected in the Physician Tables reflect the current conversion factor. In the proposed Physician Rule, CMS is mandated by law to control spending by reducing the conversion factor by 20.9% effective on April 1, 2015 if Congress does not provide a short term fix to minimize the SGR. Proposed Changes Affecting Broader Medicare Policies Comprehensive APCs - Based on the recommendation in last year’s Final Rule, CMS is proposing to move forward with the implementation of Comprehensive APCs. Comprehensive APCs combine a number of procedures required to support the delivery of the primary service into a single all-inclusive payment. Based on their proposal, CMS is making modifications to restructure all device-dependent APCs into 28 comprehensive APCs (c-APCs). To ensure appropriate accounting of all resources, CMS is proposing to apply complexity criteria for multiple procedure combinations designed as c-APCs performed on the same date of service to allow for mapping to a higher APC within that clinical family of procedures. In addition, they propose to package add-on codes performed with primary service assigned to the c-APC. According to the Agency, the policy is being pursued to improve the accuracy and transparency of their payment for certain device-dependent services. “Comprehensive APCs” result in a single all-inclusive payment for the primary service with no additional reimbursement for concomitant procedures performed during the same operative session. See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 Page 1 of 26 Change to Inpatient Admission Documentation or Certification - While CMS did not change the two-midnight stay requirement for inpatient admissions, the requirements for physician certification of inpatient admissions is proposed to be revised which should be less burdensome to both hospitals and physicians. Under this proposal, physicians would only need to certify for long-stay cases over twenty days and costly outlier cases. CMS believes that in most cases, the Business admission order, medical record and notes contain sufficient information to support the medical necessity of anUnit Name inpatient admission. Hospital Outpatient Quality Reporting (OQR) Program - The Hospital Outpatient Quality Reporting Program (Hospital OQR) is a pay for quality data reporting program implemented for outpatient hospital services. Under the Hospital OQR Program, hospitals must meet administrative, data collection and submission, validation, and publication requirements or receive a two percentage point reduction in their annual payment update (APU). CMS is proposing to remove three measures, including one cardiac care measure, OQR-4: Aspirin at Arrival, as well as two prophylactic antibiotic surgery measures as performance is high with little variation between hospitals. CMS also is proposing modifications to the Hospital OQR Program validation process and formalization of a review and corrections period. Implementation of Physician Value-Based Modifier - CMS continues to implement the value-based modifier for physicians as required by the Affordable Care Act. This modifier is similar in concept to the value-based purchasing program for hospitals. In their proposal, CMS is extending the program to solo practitioners and to physicians in groups of two or more eligible professionals for participating in the Physician Quality Reporting System (PQRS). The 2017 valuebased modifier is based on 2015 performance. CMS also proposes to increase the maximum amount of payment risk under the program from 2% in 2016 to 4% in 2017. Valuation and Coding of the Global Surgical Package for Physician Payments - Physician payments for surgical procedures also include payment for services before and after the surgery. CMS believes payment rates for many of these surgical codes may be overinflated because they have not been updated in many years. As a result, CMS is proposing over time to remove the costs of services performed before and after the surgery from the surgical procedure payment rate and have providers bill individually for those services. We will be conducting analyses and reaching out to physician societies to better understand the impact over the next few weeks. Open Payments – Physician Sunshine Act Proposed Changes - CMS proposes a policy change in the “Sunshine Act” by eliminating one exclusion for continuing medical education (CME) from physician disclosure. Currently payments provided as compensation for speaking at a CME program do not have to be reported if (1) the event is accredited by one of several organizations listed by CMS; (2) the manufacturer is not paying the covered recipient directly; and (3) if the manufacturer does not select the recipient speaker or provide a list of identifiable individuals to be considered as speakers. In response to comments, CMS is proposing to eliminate this exclusion. However, CMS will still retain exclusion under their indirect payment provisions and consider payment to be excluded from reporting if the manufacturer provides funding to a CME provider but does not select nor pay the covered recipient directly nor provide the CME provider with a list of identifiable covered recipients to be considered as speakers. Physician Quality Reporting System (PQRS) - Beginning in 2015, a downward payment adjustment will apply to eligible professionals who do not satisfactorily report data on quality measures for covered professional services or satisfactorily participate in a Qualified Clinical Data Registry (QCDR). In the CY2015, CMS has proposed to add 28 new individual measures and two measures groups to fill existing measure gaps, as well as remove 73 measures from reporting for the PQRS. These proposed changes would bring the PQRS individual measure set to 240 total measures. While some additions are not cardiovascular specific, other measures may apply. For example, one measure entitled “Closing the Referral Loop” will track the receipt of a Specialist (i.e. cardiologist or EP) Report for the percentage of patients with referrals. The percentage will be how often the referring provider receives a report from the Specialist provider to whom the patient was referred. Another possible measure is “Controlling High Blood Pressure” where the percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (<140/90 mmHg) during the measurement period. See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 Page 2 of 26 CMS is proposing to make 2015 QCDR measure data available on Physician Compare, collected at the individual level or aggregated to a higher level of the QCDR’s choosing – such as the group practice level. Business Unit Name Table Index At the end of the document the following three tables list detailed changes for select Interventional Cardiology (IC), Peripheral Intervention (PI), and Rhythm Management (RM), (reflective of Cardiac Rhythm Management and Electrophysiology) device related procedures: Table 1: Hospital Outpatient CY2015 Proposed Payment Rates Table 2: ASC CY2015 Proposed Payment Rates Table 3: Physician CY2015 Proposed Fee Schedule (Proposed rates calculated with current conversion factor of $35.8228 and do not reflect proposed 20.9% SGR reduction.) Highlights for Interventional Cardiology (IC), Peripheral Interventions (PI) and Rhythm Management (RM), are as follows: Hospital Outpatient Payments (See Table 1 for Details) Significant HOPPS/ASC Rule Proposals affecting many cardiovascular procedures Packaged services - Seven new categories of items and services are proposed for packaging into the APC procedure payment, including drugs and biologicals, diagnostics and laboratory tests, ancillary services, add-on codes, and device removal procedures. These will be bundled with the primary procedure payment and will no longer be separately paid. Comprehensive APCs – As highlighted earlier, CMS is proposing to replace all device-dependent APC’s with 28 new comprehensive APCs which include the primary service and all adjunct services provided to support the delivery of the primary service. Impact to Payments - CMS has increased payment on many APCs as a result of the packaging and composite APC proposals to reflect the increase in overall costs and elimination of separate payment for multiple procedures, additional vessels procedures and other services indicated above. CMS is proposing to pay only for the main/primary procedure or initial service code on a claim. A new status indicator “J1” will assigned to the packaged CPT codes. For cardiovascular-specific procedures, the non-weighted average outpatient proposed payment rates from Table 1 are: Interventional Cardiology increase by 49%. Peripheral Intervention increase by 2% Rhythm Management increase by 10% Interventional Cardiology Proposed comprehensive APCs will positively affect the level of reimbursement for Percutaneous Coronary Intervention (PCI) procedures. • Drug-eluting stent procedures with atherectomy, CTO, AMI, or BMS with atherectomy have proposed payment rate of $14,759. This compares to a range of CY2014 rates for these procedures of $6,364 to $7,714. • Drug-eluting stent with PTCA, bare metal stent procedures, or atherectomy without stent proposed payment rate of $9,549 compared to a range of $6,364 to $8,843. • When DES is part of CTO, AMI, atherectomy, or most second main coronary vessel procedures, the procedures will group to the higher paying APC 0319 as a ‘Complexity Adjusted APC.’ See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 Page 3 of 26 Peripheral Intervention PTA-only procedures proposed to decrease 2% to $4,334. Stent with/without PTA procedures proposed to increase 5% to $9,549. Combined PTA, Stent and atherectomy procedures proposed to decrease 5% to $14,759. Business Unit Name Embolization proposed to increase 8% to $9,549 which reflects a change from APC 0082 to 0229. Rhythm Management Proposed comprehensive APCs for Rhythm Management procedures would result in several substantial reimbursement increases, in particular for CRT and ablation procedures. CMS proposed to reassign the S-ICD system implant procedure from APC 0107 (ICD pulse generator only) to APC 0108 (ICD/CRT-D system implants). The resulting year-over- year hospital proposed payment increase is ~ $5,627 or 22.5% for 2015. This change would fully map all facility S-ICD procedures to the same payment categories as transvenous ICDs procedures. As a result of the severity adjusted comprehensive APCs, the CRT-D replacement (APC assignment change from 0107 to 0108) would increase by 22.5% and CRT-P system implant procedures would increase by 56%. Comprehensive EP studies in conjunction with ablation procedures would increase by 8%. Single chamber pacemaker implants would increase 7.8%; dual chamber pacemaker implants would decrease by 10%. Dual and single ICD implants would decrease by 4.7% WATCHMAN™ Left Atrial Appendage Closure procedure (0281T) is restricted to the inpatient hospital site of service. Ambulatory Surgical Center (See Table 2 for Detail) Peripheral Interventions All lower extremity bundled PTA, stent and atherectomy procedures are allowed in the ASC; however, less than 1% of PI procedures performed within the ASC. Rhythm Management ASC payments generally are down with the exception of S-ICD system implants. While most RM procedures are allowed in the ASC setting, less than 1% are actually performed in ASCs. S-ICD payments would increase by 18% to ~$27,000. CRT-D system implant proposed to decrease by 8.7%. ICD system implants proposed to decrease by 8.7%, ICD PG only payment rates proposed to decrease by 10.8%. Dual chamber pacemaker system implant payment rates proposed to decrease by 16%, while dual chamber pacemaker PG only payment rates proposed to increase by 7.5% Physician Payments (See Table 3 for Details) Please note that the payment rates listed in this document do not include the approximately 20.9% reduction in rates which would be required by the Sustainable Growth Rate. In addition, the calculations have been made using the CY2014 conversion factor of $35.8228 currently effective through March 31, 2015. The expectation is that Congress will continue to do short term “fixes” to minimize the Sustainable Growth Rate (SGR). Physician Fee Schedule Information (Table 3 Non-Weighted Average) The overall average change for select procedures is as follows: In-Facility In-Office Interventional Cardiology increase 0.3% N/A Peripheral Interventions no change -1% Rhythm Management increase 0.9% N/A See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 Page 4 of 26 Interventional Cardiology Coronary Stenting DES & BMS stent payment proposed to increase by 0.3% to $625. Business Unit Name CTO and DES/BMS stent with atherectomy proposed to increase 0.2% and 0.3% respectively to $700. AMI PCI proposed to increase 0.3% to $701. Structural Heart-Valves TAVR range of codes stable, up slightly 0.1%. Peripheral Interventions CPT Code Evaluation - CMS has specifically cited Thrombectomy CPT 36870 as potentially being mis-valued. The Agency welcomes stakeholder input on what the reimbursement value of this procedure should be in the future (FY 2016). Physician In-Facility reimbursement is proposed to remain relatively flat. Reimbursement of physicians for procedures done in their office is proposed to decrease 1%. Atherectomy payments increase 1.4% to $12,751. HAM payments decrease 1.3% to $1,520. Embolization payments increase 0.8% to $7,354. Thrombectomy payments decrease 0.1% to $1,865. Rhythm Management Physician Quality Report System (PQRS) - Additional proposed PQRS reporting measures for 2015 have been added which are applicable to Rhythm Management including Cardiac Tamponade and/or Pericardiocentesis following Atrial Fibrillation Ablation and Infection within 180 days of Cardiac Implantable Electronic Device (CIED) Implantation, Replacement, or Revision. Payment rates for device implants would remain relatively flat at a 0.81% increase. Ablation and mapping procedures would remain relatively flat at a 0.91% increase. Comments or Questions If you have questions or would like additional information please contact: Interventional Cardiology (IC)/Peripheral Interventions (PI) Tom Meskan – IC and PI 763-494-2016 [email protected] Deb Lorenz – IC 763-494-2112 [email protected] Brent Hale - PI 763-494-1448 [email protected] Rhythm Management (RM) Call 1-800-CARDIAC (request reimbursement support) [email protected] See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 Page 5 of 26 1 CPT Copyright 2014 American Medical Association. All rights reserved. CPT is a registered trademark of the American Business Unit Name Medical Association. Applicable FARS/DFARS Restrictions Apply to Government Use. Fee schedules, relative value units, conversion factors, and/or related components are not assigned by the AMA, are not part of CPT®, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein. 2 Please note: this coding information may include some codes for procedures for which Boston Scientific currently offers no cleared or approved products. In those instances, such codes have been included solely in the interest of providing users with comprehensive coding information and are not intended to promote the use of any Boston Scientific products for which they are not cleared or approved. Note: Some of the codes presented above may be used to code for a variety of procedures (diagnostic and therapeutic) employed in the field of electrophysiology, including atrial fibrillation, atrial flutter, AV Node, SVT and VT ablations. Please note that no Boston Scientific products are approved for sale in the US for ablation for atrial fibrillation. See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 Page 6 of 26 Table 1: CY2015 Hospital Outpatient Proposed Payment Rates for Select Procedures APC Descriptor Interventional Cardiology Diagnostic Cardiac Catheterization 0080 Coronary or Non‐Coronary Atherectomy 0082 Level I Endovascular Procedures * 0083 0104 0229 * 0229 0319 Transcatheter Placement of Intracoronary Stents Level II Endovascular Procedures (Atherectomy, BMS, BMS AMI, BMS CTO, BMS Bypass Graft; Previous APC 104) Level II Endovascular Procedures (DES w/PTCA and DES Bypass Graft; Previous APC 656) Level III Endovascular Procedures (BMS w Atherectomy; Previous APC 104) Level III Endovascular Procedures (DES w Atherectomy, DES CTO, or DES AMI; Previous APC 656) Transcatheter Placement of Intracoronary Drug‐Eluting 0656 Stents Peripheral Interventions 0082 Coronary or Non‐Coronary Atherectomy Level I Endovascular Procedures (PTA) * 0083 Thrombectomy 0088 Vascular Reconstruction/Fistula Repair 0093 Level I Percutaneous Abdominal and Biliary Procedures 0152 (Biliary Stenting) Level II Cystourethroscopy and other Genitourinary 0161 Procedures Level II Endovascular Procedures (PTA & Stent, * 0229 Embolization) Level IV Endovascular Procedures (PTA, Stent & * 0319 Atherectomy) Level II Endoscopy Lower Airway 0415 Level II Tube Changes and Repositioning 0427 0319 0652 Insertion of Intraperitoneal and Pleural Catheters Level I Angiography and Venography 0668 Thrombolysis and Other Device Revisions 0676 Brachytherapy, non‐str,Yttrium‐90 2616 Rhythm Management Level III Pacemaker and Similar Procedures (PM system, 0089 Previous APC 0655) Level II Pacemaker and Similar Procedures (PM 0090 replacement or lead only) 0655 Pacemaker – Dual Chamber System S‐ICD Implant ‐ Level II ICD and Similar Procedures 0108 (Previous APC 0107) 0108 0107 0080 Level II ICD and Similar Procedures (ICD or CRTD System or CRT-D Replacement) Level I ICD and Similar Procedures (ICD/S‐ICD PG only, Previous APC 0107) Diagnostic Cardiac Catheterization CY2015 Variance 2015 CY2014 Final Proposed Proposed vs. 2014 Rate Rate Final $2,600 $4,334 $2,587 $13 Proposed to be deleted in CY2015 $4,410 ‐$76 % YoY Change 0.51% ‐1.73% Proposed to be deleted in CY2015 $9,549 $6,364 $3,185 50.04% $9,549 $7,714 $1,835 23.78% $14,759 $6,364 $8,395 131.91% $14,759 $7,714 $7,045 91.33% Proposed to be deleted in CY2015 $4,334 $3,281 $2,443 Proposed to be deleted in CY2015 $4,410 ‐$76 $3,272 $9 $2,847 ‐$404 ‐1.73% 0.29% ‐14.18% $1,832 $1,788 $44 2.45% $1,235 $1,205 $30 2.51% $9,549 $9,120 $429 4.70% $14,759 $15,510 ‐$751 ‐4.84% $2,261 $1,454 $2,000 $1,306 $261 $148 13.05% 11.30% $2,641 $2,417 $224 9.26% $843 $200 $16,017 $827 $184 $16,829 $16 $16 ‐$812 1.95% 8.75% ‐4.82% $9,478 $10,588 ‐$1,110 ‐10.48% $6,649 NA NA NA $16,536 $10,588 $5,947 56.17% $30,645 $25,018 $5,627 22.49% $30,645 $32,145 ‐$1,500 ‐4.66% $23,083 $25,018 ‐$1,935 ‐7.74% $2,600 $2,587 $13 0.51% See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 7 Table 1: CY2015 Hospital Outpatient Proposed Payment Rates for Select Procedures APC CY2015 Variance 2015 CY2014 Final Proposed Proposed vs. 2014 Rate Rate Final Descriptor % YoY Change 0084 0085 Level I EP Procedures Level II EP Procedures $881 $4,592 $754 $4,233 $127 $359 16.85% 8.48% 0086 Level III Electrophysiologic Procedures (EP study + Ablation, Previous APC 8000) $14,169 $13,115 $1,054 8.04% * Symbol notes comprehensive APC See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 8 Table 2: Ambulatory Surgical Center (ASC) ASC CY2015 Proposed Payment Rates for Select Procedures CY2015 CY2014 Final Variance 2015 Proposed Proposed Abbreviated (Partial) Description vs. 2014 Final Payment Payment $ $ $ % CPT® Peripheral Interventions Hemodialysis PTA 35476 Transluminal balloon angioplasty, percutaneous; venous Transluminal balloon angioplasty, percutaneous; brachiocephalic 35475 trunk or branches, each vessel Iliac Revascularization * 37220 37221 Transluminal peripheral angioplasty, percutaneous; iliac Revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within same vessel, when performed $1,243 $923 $319 34.57% $1,318 $978 $339 34.69% $2,069 $2,436 ($367) ‐15.08% $6,023 $5,038 $985 19.55% $1,170 $1,703 ($533) ‐31.29% $1,776 $1,807 ($31) ‐1.74% $1,224 $1,105 $119 10.77% $2,194 $2,268 ($74) ‐3.28% $992 $643 $643 $1,292 $669 $643 $988 $722 $722 $1,335 $666 $722 $4 ($79) ($79) ($43) $3 ($79) 0.39% ‐10.89% ‐10.89% ‐3.24% 0.44% ‐10.89% * Iliac procedures shown as sample: All 15 LE bundled codes (37220‐37235) are allowed in the ASC Thrombectomy Thrombectomy, percutaneous, arteriovenous fistula, autogenous or nonautogenous graft (includes mechanical thrombus extraction and intra‐graft thrombolysis) Thrombectomy, with or without catheter; axillary and subclavian 34490 vein, by arm incision Trach Bronch Stent Bronchosopy (rigid or flexible); with tracheal dilation and placement 31631 of tracheal stent Biliary Stenting Biliary endoscopy, percutaneous via T‐tube or other tract; with 47556 dilation of biliary duct stricture(s) with stent Insert catheter, bile duct 47510 Change bile duct catheter 47525 Revise/reinsert bile tube 47530 Insert abdom drain, perm 49421 Insert kidney drain 50392 Exchange drainage catheter 49423 36870 See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 9 CPT® Table 2: Ambulatory Surgical Center (ASC) ASC CY2015 Proposed Payment Rates for Select Procedures CY2015 CY2014 Final Variance 2015 Proposed Proposed Abbreviated (Partial) Description vs. 2014 Final Payment Payment $ $ $ % Rhythm Management Pacemaker ‐ dual chamber system implant 33208 Pacemaker ‐ dual chamber pulse generator only 33213 ICD system implant 33249 ICD pulse generator only 33240 S‐ICD System Implant 0319T 33249 + 33225 CRT-D System implant (33249 & 33225 when performed on the same day) $7,799 $7,799 $27,005 $20,400 $27,005 $9,286 $7,256 $29,600 $22,882 $22,882 ($1,487) $543 ($2,595) ($2,481) $4,123 ‐16.01% 7.48% ‐8.77% ‐10.84% 18.02% $29,600 $29,600 $0 0.00% See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 10 Modifier Table 3: Physician Fee Schedule CY2015 Proposed Rule Payment Rates Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed vs. Proposed In‐ CPT® Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Interventional Cardiology Diagnostic Catheterization $149 ($2) ‐1.42% $149 ($2) ‐1.42% 93451 26 Right heart catheterization including measurement(s) of oxygen saturation and cardiac output, when performed NA NA NA $793 $4 0.45% 93451 $262 ($4) ‐1.35% $262 ($4) ‐1.35% 93452 26 Left heart catheterization including intraprocedural injection(s) for left ventriculography; imaging supervision and NA NA NA $896 $9 1.05% 93452 $344 ($4) ‐1.03% $344 ($4) ‐1.03% 93453 26 Combined right heart cath and left heart catheterization including intraprocedural injection(s) for left ventriculography, NA NA NA $1,153 $5 0.41% 93453 $263 ($4) ‐1.34% $263 ($4) ‐1.34% 93454 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $907 $3 0.36% 93454 $304 ($4) ‐1.16% $304 ($4) ‐1.16% 93455 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $1,056 $4 0.37% 93455 $339 ($3) ‐0.84% $339 ($3) ‐0.84% 93456 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $1,135 $3 0.28% 93456 $379 ($4) ‐1.03% $379 ($4) ‐1.03% 93457 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $1,282 $3 0.20% 93457 $320 ($5) ‐1.65% $320 ($5) ‐1.65% 93458 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $1,086 $3 0.23% 93458 $362 ($5) ‐1.37% $362 ($5) ‐1.37% 93459 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $1,200 $4 0.30% 93459 $403 ($5) ‐1.23% $403 ($5) ‐1.23% 93460 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary $5 0.39% NA NA NA $1,289 93460 $446 ($5) ‐1.11% $446 ($5) ‐1.11% 93461 26 Catheter placement in coronary artery(s) for coronary angiography, including intraprocedural injection(s) for coronary NA NA NA $1,474 $6 0.39% 93461 93462 Left heart catheterization by transseptal puncture through intact septum or by transapical puncture (List separately in addition to code for primary procedure) $214 ($0) ‐0.17% $214 ($0) ‐0.17% 93463 Pharmacologic agent administration (eg, inhaled nitric oxide, intravenous infusion of nitroprusside, dobutamine, milrinone, or other agent) including assessing hemodynamic measurements before, during, after and repeat pharmacologic agent administration, when performed (List separately in addition to code for primary procedure) $101 ($8) ‐7.54% $101 ($8) ‐7.54% Physiologic exercise study (eg, bicycle or arm ergometry) including assessing hemodynamic measurements before and $89 NA ($9) NA ‐9.45% NA $89 $278 ($9) ($6) ‐9.45% ‐2.27% 93464 93464 26 93531 26 Combined right heart catheterization and retrograde left heart cath, for congenital cardiac anomalies $451 ($12) ‐2.63% $451 ($12) ‐2.63% 93532 26 Combined right heart catheterization and transseptal left heart cath through intact septum with or w/o retrograde left heart catheterization, for congenital cardiac anomalies $559 $4 0.65% $559 $4 0.65% See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 11 CPT® Modifier 93533 26 Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Combined right heart catheterization and transseptal left heart cath through existing septal opening, with or w/o retrograde left heart catheterization, for congenital cardiac anomalies $374 $2 0.48% $374 $2 0.48% 93565 Injection procedure during cardiac catheterization including imaging supervision and interpretation, and report; for selective left ventricular or left arterial angiography (List separately in addition to code for primary procedure) $47 $3 5.65% $47 $3 5.65% 93566 Injection procedure during cardiac catheterization including imaging supervision and interpretation, and report; for selective right ventricular or right atrial angiography (List separately in addition to code for primary procedure) $48 $4 8.06% $174 $1 0.62% 93567 Injection procedure during cardiac catheterization including imaging supervision and interpretation, and report; for supravalvular aotography (List separately in addition to code for primary procedure) $54 $4 8.63% $143 $1 0.50% 93568 Injection procedure during cardiac catheterization including imaging supervision and interpretation, and report; for pulmonary angiography (List separately in addition to code for primary procedure) $49 $4 7.94% $155 $1 0.70% $563 $2 0.32% NA NA NA $0 $0 NA $0 $0 NA $669 $1 0.21% NA NA NA $0 $0 NA $0 $0 NA $625 $2 0.34% NA NA NA Diagnostic Cath Injection Angioplasty without Stent Percutaneous transluminal coronary angioplasty; single major 92920 coronary artery or branch 92921 Percutaneous transluminal coronary angioplasty; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) Atherectomy without Stent Percutaneous transluminal coronary atherectomy, with 92924 coronary angioplasty when performed; single major coronary artery or branch 92925 Percutaneous transluminal coronary atherectomy, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) Stent with Angioplasty 92928 Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; single major coronary artery or branch See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 12 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Percutaneous transcatheter placement of intracoronary stent(s), with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) 92929 $0 $0 NA $0 $0 NA $700 $2 0.31% NA NA NA Stent with Atherectomy 92933 Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; single major coronary artery or branch 92934 Percutaneous transluminal coronary atherectomy, with intracoronary stent, with coronary angioplasty when performed; each additional branch of a major coronary artery (list separately in addition to code for primary procedure) $0 $0 NA $0 $0 NA 92937 Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; single vessel $625 $2 0.29% NA NA NA 92938 Percutaneous transluminal revascularization of or through coronary artery bypass graft (internal mammary, free arterial, venous), any combination of intracoronary stent, atherectomy and angioplasty, including distal protection when performed; each additional branch subtended by the bypass graft (list separately in addition to code for primary procedure) $0 $0 NA $0 $0 NA $701 $2 0.26% NA NA NA $700 $1 0.21% NA NA NA Bypass Graft Acute Myocardial Infarction 92941 Percutaneous transluminal revascularization of acute total/subtotal occlusion during acute myocardial infarction, coronary artery or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty, including aspiration thrombectomy when performed, single vessel Chronic Total Occlusion 92943 Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; single vessel See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 13 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Percutaneous transluminal revascularization of chronic total occlusion, coronary artery, coronary artery branch, or coronary artery bypass graft, any combination of intracoronary stent, atherectomy and angioplasty; each additional coronary artery, coronary artery branch, or bypass graft (list separately in addition to code for primary procedure) 92944 $0 $0 NA $0 $0 NA Percutaneous transluminal coronary thrombectomy mechanical $183 $1 0.39% NA NA NA 26 Intravascular ultrasound (coronary vessel or graft) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; initial vessel (List separately in addition to code for primary procedure) $100 $10 10.67% $100 $10 10.67% 26 Intravascular ultrasound (coronary vessel or graft) during diagnostic evaluation and/or therapeutic intervention including imaging supervision, interpretation and report; each additional vessel (List separately in addition to code for primary procedure) $81 $8 10.29% $81 $8 10.29% 26 Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; each additional vessel (List separately in addition to code for primary procedure) $100 $10 10.67% $100 $10 10.67% 26 Intravascular Doppler velocity and/or pressure derived coronary flow reserve measurement (coronary vessel or graft) during coronary angiography including pharmacologically induced stress; initial vessel (List separately in addition to code for primary procedure) $80 $7 9.27% $80 $7 9.27% $1,257 $1,299 ($113) ($116) ‐8.26% ‐8.20% NA NA NA NA NA NA $1,020 ($93) ‐8.37% NA NA NA Thrombectomy 92973 IVUS 92978 92979 FFR 93571 93572 Valvuloplasty 92986 Percutaneous balloon valvuloplasty; aortic valve 92987 Percutaneous balloon valvuloplasty; mitral valve 92990 Percutaneous balloon valvuloplasty; pulmonary valve Transcatheter Aortic Valve Replacement 33361 Transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; percutaneous femoral artery approach $1,406 $2 0.15% NA NA NA 33362 Transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; open femoral artery approach $1,536 $1 0.09% NA NA NA See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 14 33363 33364 33365 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Transcatheter aortic valve replacement (tavr/tavi) with $1,615 $26 1.65% NA NA NA prosthetic valve; open axillary artery approach Transcatheter aortic valve replacement (tavr/tavi) with $1,672 $0 0.02% NA NA NA prosthetic valve; open iliac artery approach Transcatheter aortic valve replacement (tavr/tavi) with $1,841 ($3) ‐0.14% NA NA NA prosthetic valve; transaortic approach (e.g., median sternotomy, mediastinotomy) 33366 Transcatheter aortic valve replacement (TAVR/TAVI) with prosthetic valve; transapical exposure (eg, left thoracotomy) $2,007 $12 0.61% NA NA NA 33367 Transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; cardiopulmonary bypass support with percutaneous peripheral arterial and venous cannulation (e.g., femoral vessels) (list separately in addition to code for primary procedure) $640 ($4) ‐0.56% NA NA NA 33368 Transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; cardiopulmonary bypass support with open peripheral arterial and venous cannulation (e.g., femoral, iliac, axillary vessels) (list separately in addition to code for primary procedure) $775 ($5) ‐0.64% NA NA NA 33369 Transcatheter aortic valve replacement (tavr/tavi) with prosthetic valve; cardiopulmonary bypass support with central arterial and venous cannulation (e.g., aorta, right atrium, pulmonary artery) (list separately in addition to code for primary procedure) $1,024 ($5) ‐0.52% NA NA NA See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 15 Modifier Table 3: Physician Fee Schedule CY2015 Proposed Rule Payment Rates Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed vs. Proposed In‐ CPT® Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Peripheral Interventions Non‐Coronary Angioplasty Transluminal balloon angioplasty, percutaneous; 35475 $349 ($6) ‐1.81% $1,588 ($22) ‐1.36% brachiocephalic trunk or branches, each vessel 35476 Transluminal balloon angioplasty, percutaneous; venous Radiological S&I (Non‐Cor Angioplasty) 75962 26 Transluminal balloon angioplasty, peripheral artery other than cervical carotid, renal or other visceral artery, iliac or lower 75962 75964 26 Transluminal balloon angioplasty, each additional peripheral artery other than cervical carotid, renal or other visceral artery, 75964 75966 26 Transluminal balloon angioplasty, renal/visceral artery, radiological S&I 75966 75968 26 Transluminal balloon angioplasty, renal/visceral, each additional artery, S&I (List separately in addition to code for primary 75968 75978 26 Transluminal balloon angioplasty, venous (eg, subclavian stenosis), radiological S&I 75978 Iliac Artery Revascularization $282 ($1) ‐0.38% $1,452 ($18) ‐1.19% $27 NA $18 NA $65 NA $18 NA $27 NA $0 NA ($0) NA $1 NA $1 NA $0 NA 0.00% NA ‐1.96% NA 2.25% NA 4.08% NA 0.00% NA $27 $140 $18 $87 $65 $172 $18 $89 $27 $138 $0 ($8) ($0) ($8) $1 ($4) $1 $0 $0 ($8) 0.00% ‐5.11% ‐1.96% ‐7.95% 2.25% ‐2.04% 4.08% 0.40% 0.00% ‐5.42% 37220 Revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal angioplasty $435 ($1) ‐0.16% $3,211 ($24) ‐0.75% 37221 Revascularization, endovascular, open or percutaneous, iliac artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within same vessel, when performed $534 $4 0.68% $4,736 ($14) ‐0.29% 37222 Revascularization, endovascular, open or percutaneous, iliac artery, each additional ipsilateral iliac vessel; with transluminal angioplasty (List separately in addition to code for primary procedure) $196 $0 0.00% $901 ($10) ‐1.14% 37223 Revascularization, endovascular, open or percutaneous, iliac artery, each additional ipsilateral iliac vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed (List separately in addition to code for primary procedure) $225 $1 0.32% $2,640 $2 0.07% $479 ($3) ‐0.60% $3,896 ($23) ‐0.59% $648 ($2) ‐0.28% $11,210 $20 0.18% Femoral/Popliteal Artery Revascularization Revascularization, endovascular, open or percutaneous, 37224 femoral/popliteal artery(s), unilateral; with transluminal angioplasty 37225 Revascularization, endovascular, open or percutaneous, femoral/popliteal artery(s), unilateral; with atherectomy, includes angioplasty within same vessel, when performed See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 16 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % 37226 Revascularization, endovascular, open or percutaneous, femoral/popliteal artery(s),unilateral;with transluminal stent placement(s), includes angioplasty within the same vessel, when performed $562 $29 5.38% $9,218 $30 0.33% 37227 Revascularization, endovascular, open or percutaneous, femoral/popliteal artery(s), unilateral; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed $779 ($3) ‐0.41% $15,143 $79 0.52% $5,542 ($27) ‐0.48% BSC currently has no stents FDA‐approved for use in the infrainguinal regions of the lower extremities Tibeal / Peroneal Artery Revascularization Revascularization, endovascular, open or percutaneous, $585 ($2) ‐0.37% 37228 tibeal\peroneal artery, unilateral, initial vessel; with transluminal angioplasty 37229 Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, initial vessel; with atherectomy, includes angioplasty within the same vessel, when performed $756 ($3) ‐0.42% $11,062 $41 0.37% 37230 Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, initial vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed $746 $10 1.36% $8,455 $21 0.25% 37231 Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, initial vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed $810 $4 0.49% $13,589 $126 0.93% 37232 Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, each additional vessel; with transluminal angioplasty (List separately in addition to code fore primary procedure) $212 ($1) ‐0.34% $1,236 ($2) ‐0.17% 37233 Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, each additional vessel; with atherectomy, includes angioplasty within the same vessel, when performed (List separately in addition to code fore primary procedure) $345 ($3) ‐0.82% $1,496 $10 0.65% 1.09% $3,951 $16 0.41% BSC currently has no stents FDA‐approved for use in the infrainguinal regions of the lower extremities 37234 Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s), includes angioplasty within the same vessel, when performed (List separately in addition to code fore primary procedure) $298 $3 See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 17 37235 37236 37237 37238 37239 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Revascularization, endovascular, open or percutaneous, tibeal\peroneal artery, unilateral, each additional vessel; with transluminal stent placement(s) and atherectomy, includes angioplasty within the same vessel, when performed (List separately in addition to code fore primary procedure) Transcatheter placement of an intravascular stent(s) (except lower extremity, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological supervision and interpretation and including all angioplasty within the same vessel, when performed; initial artery Transcatheter placement of an intravascular stent(s) (except lower extremity, cervical carotid, extracranial vertebral or intrathoracic carotid, intracranial, or coronary), open or percutaneous, including radiological supervision and interpretation and including all angioplasty within the same vessel, when performed; each additional artery (List separately in addition to code for primary procedure) Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; initial vein Transcatheter placement of an intravascular stent(s), open or percutaneous, including radiological supervision and interpretation and including angioplasty within the same vessel, when performed; each additional vein (List separately in addition to code for primary procedure) $411 ($17) ‐3.94% $4,249 $232 5.78% $458 ($24) ‐4.98% $2,834 ($29) ‐1.00% $225 $0 0.00% $1,234 ($9) ‐0.75% $333 ($5) ‐1.48% $4,182 ($4) ‐0.09% $167 $9 5.92% $2,073 ($8) ‐0.38% Catheter Access 36140 Introduction of needle or intracatheter; extremity artery $107 ($0) ‐0.33% $444 ($1) ‐0.32% 36147 36148 Access av dial grft for eval Access av dial grft for proc $194 $51 ($0) $0 ‐0.18% 0.70% $850 $266 ($3) $1 ‐0.34% 0.27% 36160 Introduction of needle or intracatheter, aortic, translumbar $129 ($4) ‐3.22% $504 ($16) ‐3.10% $159 $0 0.23% $634 ($0) ‐0.06% 36200 Introduction of catheter, aorta Catheter Placement 36215 Selective catheter placement, arterial system; each first order thoracic or brachiocephalic branch, within a vascular family $245 ($7) ‐2.70% $1,145 $25 2.21% 36216 Selective catheter placement, arterial system; initial second order thoracic or brachiocephalic branch, within a vascular family $285 ($3) ‐1.00% $1,190 ($73) ‐5.81% See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 18 36217 36218 36245 36246 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Selective catheter placement, arterial system; initial third order $337 ($8) ‐2.39% $1,924 ($249) ‐11.44% or more selective thoracic or brachiocephalic branch, within a vascular family Selective catheter placement, arterial system; additional second order, third order, and beyond, thoracic or brachiocephalic branch, within a vascular family (list in addition to code for initial second or third order vessel as appropriate) Selective catheter placement, arterial system; each first order abdominal, pelvic, or lower extremity artery branch, within a vascular family Selective catheter placement, arterial system; initial second order abdominal, pelvic, or lower extremity artery branch, within a vascular family $55 $0 0.00% $188 ($15) ‐7.56% $263 ($4) ‐1.34% $1,389 $5 0.34% $280 $0 0.00% $907 $0 0.04% 36247 Selective catheter placement, arterial system; initial third order or more selective abdominal, pelvic, or lower extremity artery branch, within a vascular family $331 ($4) ‐1.07% $1,603 ($4) ‐0.27% 36248 Selective catheter placement, arterial system; additional second order, third order, and beyond, abdominal, pelvic, or lower extremity artery branch, within a vascular family (List in addition to code for initial second or third order vessel as appropriate $52 ($2) ‐3.36% $155 ($1) ‐0.69% Carotid Artery Stenting 37215 Transcatheter placement of intravascular stent(s), cervical carotid artery, percutaneous; with distal embolic protection $1,135 $7 0.64% NA NA NA 37216 Transcatheter placement of intravascular stent(s), cervical carotid artery, percutaneous; without distal embolic protection $1,049 ($1) ‐0.07% NA NA NA 37191 Insertion of inferior vena cava filter, endovascular approach including vascular access, vessel selection and radiological supervision and interpretation (including ultrasound) when performed. $249 ($1) ‐0.29% $2,676 ($8) ‐0.28% 37192 Repositioning of inferior vena cava filter, endovascular approach including vascular access, vessel selection and radiological supervision and interpretation (including ultrasound) when performed. $425 $48 12.75% $1,738 $183 11.80% 37193 Retrieval (removal) of inferior vena cava filter, endovascular approach including vascular access, vessel selection and radiological supervision and interpretation (including ultrasound) when performed. $382 ($3) ‐0.84% $1,630 ($8) ‐0.48% Vena Cava Filters See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 19 Modifier Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. CPT® Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Thrombectomy 36870 Thrombectomy, percutaneous, arteriovenous fistula, autogenous or nonautogenous graft (includes mechanical thrombus extraction and intra‐graft thrombolysis) $313 ($0) ‐0.11% $1,865 ($2) ‐0.10% 34101 Thrombectomy, with or without catheter; axillary, brachial, innominate, subclavian artery, by arm incision $632 ($3) ‐0.51% NA NA NA $629 ($6) ‐0.96% NA NA NA $1,085 ($8) ‐0.75% NA NA NA $641 $1 0.22% NA NA NA Thrombectomy, with or without catheter; radial or ulnar artery, by arm incision Thrombectomy, with or without catheter; femoral\popliteal, 34201 aortoiliac artery, by leg incision Thrombectomy, with or without catheter; axillary and 34490 subclavian vein, by arm incision Non‐Coronary IVUS 34111 37250 Intravascular ultrasound (non‐coronary vessel) during diagnostic evaluation and/or therapeutic intervention; initial vessel (List separately in addition to code for primary procedure) $111 ($1) ‐0.64% NA NA NA 37251 Intravascular ultrasound (non‐coronary vessel) during diagnostic evaluation and/or therapeutic intervention; each additional vessel (List separately in addition to code for primary procedure) $84 ($0) 0.00% NA NA NA Radiological S&I (Non‐Cor IVUS) 75945 26 Intravascular ultrasound (peripheral vessel) radiological supervision and interpretation; initial vessel $20 $0 1.79% $20 $0 1.79% 75946 26 each additional non‐coronary vessel (List separately in addition to code for primary procedure) $20 $0 0.00% $20 $0 0.00% 0.65% NA 1.66% NA 1.26% NA $56 $162 $66 $188 $58 $151 $0 ($15) $1 ($23) $1 ($14) 0.65% ‐8.32% 1.66% ‐11.02% 1.26% ‐8.68% 0.62% NA 0.56% NA 7.79% NA $58 $171 $65 $184 $59 $164 $0 ($12) $0 ($21) $4 ($10) 0.62% ‐6.65% 0.56% ‐10.14% 7.79% ‐5.77% 0.15% NA NA NA Angiograms 75710 26 Angiography, extremity, unilateral, radiological supervision and $56 $0 interpretation 75710 NA NA 75716 26 Angiography, extremity, bilateral, radiological supervision and $66 $1 interpretation 75716 NA NA 75726 26 Angiography, visceral, selective or supraselective (with or $58 $1 without flush aortogram), radiological supervision and 75726 NA NA BSC currently has no stents FDA‐approved for use in the infrainguinal regions of the lower extremities 75731 26 Angiography, adrenal, unilateral, selective, radiological $58 $0 supervision and interpretation 75731 NA NA 75733 26 Angiography, adrenal, bilateral, selective, radiological $65 $0 supervision and interpretation 75733 NA NA 75736 26 Angiography, pelvic, selective or supraselective, radiological $59 $4 supervision and interpretation 75736 NA NA Bronchoscopy 31631 Bronchosopy; with placement of tracheal stent(s) (inludes tracheal/bronchial dilation as required) $238 $0 See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 20 Modifier Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. CPT® Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Biliary Stenting Biliary endoscopy, percutaneous via T‐Tube or other tract; with dilation of biliary duct stricture(s) with stent $436 ($1) ‐0.25% NA NA NA Radiological S&I (Biliary stenting) Percutaneous transhepatic dilation of biliary duct stricture with 74363 26 or without placement of stent, radiological supervision and interpretation Transhepatic Shunts (TIPS) $45 ($0) ‐0.79% $45 ($0) ‐0.79% 37182 Insertion of transvenous intrahepatic portosystemic shunt(s) (TIPS) (includes venous access, hepatic and portal vein cath, portography with hemodynamic evaluation, intrahepatic tract formation/dilation, stent placement and all associated imaging and guidance and documentation) $873 ($2) ‐0.25% NA NA NA 37183 Revision of transvenous intrahepatic portosystemic shunt(s) (TIPS)(includes venous access, hepatic and portal vein cath, portography with hemodynamic evaluation, intrahepatic tract recanulization / dilation, stent placement and all associated imaging and guidance and documentation) $411 ($1) ‐0.17% $6,001 $45 0.76% 37241 Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; venous, other than hemorrhage (eg, congenital or acquired venous malformations, venous and capillary hemangiomas, varices, varicoceles) $462 ($1) ‐0.31% $4,667 $33 0.70% 37242 Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; arterial, other than hemorrhage or tumor (eg, congenital or acquired arterial malformations, arteriovenous malformations, arteriovenous fistulas, aneurysms, pseudoaneurysms) $516 ($2) ‐0.35% $7,867 $62 0.79% 37243 Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for tumors, organ ischemia, or infarction $615 ($2) ‐0.35% $9,932 $78 0.80% 37244 Vascular embolization or occlusion, inclusive of all radiological supervision and interpretation, intraprocedural roadmapping, and imaging guidance necessary to complete the intervention; for arterial or venous hemorrhage or lymphatic extravasation $718 ($3) ‐0.35% $6,950 $51 0.73% 47556 Embolization See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 21 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Drainage 47510 Introduction of percutaneous transhepatic catheter for biliary drainage Introduction of percutaneous transhepatic stent for internal and external biliary drainage Change of percutaneous biliary drainage catheter Revision and/or reinsertion of transhepatic tube Insertion of intraperitoneal cannula or catheter for drainage or dialysis; permanent Introduction of intracatheter or catheter into renal pelvis for drainage and/or injection, percutaneous $487 $0 0.00% NA NA NA $597 ($1) ‐0.18% NA NA NA $87 $364 $0 $2 0.00% 0.49% $528 $1,399 $7 $4 1.30% 0.31% $238 $3 1.07% NA NA NA $186 $0 0.19% NA NA NA Exchange of previously placed abscess or cyst drainage catheter under radiological guidance (separate procedure) $75 $0 0.00% $557 $2 0.39% 26 Percutaneous transhepatic biliary drainage with contrast monitoring, radiological supervision and interpretation $74 $1 0.98% $74 $1 0.98% 75982 26 Percutaneous placement of drainage catheter for combined internal and external biliary drainage or of a drainage stent for internal biliary drainage in patients with an inoperable mechanical biliary obstruction, radiological supervision and interpretation $73 $0 0.49% $73 $0 0.49% 75984 26 Change of percutaneous tube or drainage catheter with contrast monitoring (eg, genitourinary system, abscess), radiological supervision and interpretation $36 $0 0.00% $36 $0 0.00% 47511 47525 47530 49421 50392 49423 75980 See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 22 Modifier Table 3: Physician Fee Schedule CY2015 Proposed Rule Payment Rates Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed vs. Proposed In‐ CPT® Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Rhythm Management Device Implant Procedures $477 $5 1.14% NA NA NA 33206 Insertion of heart pacemaker and atrial electrode 33207 Insertion of heart pacemaker and ventricular electrode $507 $4 0.85% NA NA NA 33208 Insertion of heart pacemaker with transvenous electrode $549 $5 0.86% NA NA NA 33212 Insertion of pulse generator only with existing single lead $343 $2 0.53% NA NA NA 33213 Insertion of pulse generator only with existing dual lead $358 $2 0.50% NA NA NA 33221 Insertion of pulse generator only with existing mulitple leads $384 $5 1.32% NA NA NA 33214 33215 33216 33217 33218 33220 33222 33223 33225 Upgrade of pacemaker system Reposition pacing‐defib lead Insert lead pace‐defib, one Insert lead pace‐defib, dual Repair of single lead, pacer or ICD Repair of 2 leads, pacer or ICD Revise/relocate pocket, pacemaker Revise pocket, defib L ventric pacing lead (add‐on) $503 $318 $394 $387 $413 $413 $359 $433 $483 $1 $2 $4 $2 $6 $3 $2 $3 $5 0.14% 0.68% 1.10% 0.56% 1.41% 0.70% 0.60% 0.75% 0.97% NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 33227 Removal and replacement of pacemaker gen, single lead $361 $2 0.50% NA NA NA 33228 Removal and replacement of pacemaker gen, dual lead $376 $2 0.57% NA NA NA 33229 Removal and replacement of pacemaker gen, multiple lead $396 $3 0.73% NA NA NA 33233 33234 33235 33240 33230 Removal of pacemaker system gen only Removal of pacemaker system lead, single Removal pacemaker electrode, dual lead Insert pulse generator with exisitng single lead Insert ICD pulse generator with exisitng dual leads $250 $512 $667 $389 $407 $3 $6 $6 $1 ($2) 1.31% 1.13% 0.87% 0.37% ‐0.44% NA NA NA NA NA NA NA NA NA NA NA NA NA NA NA 33231 Insert ICD pulse generator with exisitng multiple leads $429 $8 1.87% NA NA NA 33241 33262 33263 Remove pulse generator only Removal and replacement of defib gen, single lead Removal and replacement of defib gen, dual lead $235 $397 $413 $3 $3 $3 1.23% 0.73% 0.79% NA NA NA NA NA NA NA NA NA 33264 Removal and replacement of defib gen, multiple lead $429 $3 0.59% NA NA NA $896 $955 $8 $10 0.89% 1.02% NA NA NA NA NA NA $342 NA NA $22 NA NA $4 NA NA $1 NA NA 1.06% NA NA 3.39% NA NA $342 $38 $16 $22 $50 $18 $4 $1 $0 $1 $0 $0 1.06% 1.94% 0.00% 3.39% 0.00% 2.08% 33244 Remove eltrd, transven 33249 Eltrd/insert pace‐defib Device Evaluation 93641 26 Electrophysiology evaluation ‐ICD system 93288 93288 TC PM Interrogation in person all lead configurations 93288 26 93279 93279 TC PM Programming eval 1 lead See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 23 93279 93280 93280 93280 93281 93281 93281 93289 93289 93289 93282 93282 93282 93283 93283 93283 93284 93284 93284 93291 93291 93291 93285 93285 93285 93290 93290 93290 93292 93292 93292 93286 93286 93286 93287 93287 93287 93293 93293 93293 93228 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % 26 $33 ($0) ‐1.09% $33 ($0) ‐1.09% NA NA NA $59 $0 0.00% TC PM Programming eval 2 lead NA NA NA $20 $0 0.00% 26 $39 $0 0.00% $39 $0 0.00% NA NA NA $69 $0 0.52% TC PM Programming eval 3 lead NA NA NA $23 $0 1.56% 26 $45 $0 0.00% $45 $0 0.00% NA NA NA $66 $0 0.55% TC ICD interrogation in person all lead configurations NA NA NA $20 $0 1.85% 26 $46 $0 0.00% $46 $0 0.00% NA NA NA $64 $1 1.14% TC ICD Programming eval 1 lead NA NA NA $20 $0 1.79% 26 $43 $0 0.83% $43 $0 0.83% NA NA NA $82 $0 0.44% TC ICD Programming eval 2 lead NA NA NA $24 $0 1.52% 26 $58 $0 0.00% $58 $0 0.00% NA NA NA $91 $1 0.79% TC ICD Programming eval 3 lead NA NA NA $27 $0 1.33% 26 $64 $0 0.56% $64 $0 0.56% NA NA NA $37 $0 0.99% TC ILR Innterrogation in person NA NA NA $15 $0 0.00% 26 $22 $0 1.67% $22 $0 1.67% NA NA NA $43 $1 1.71% TC ILR Programming eval NA NA NA $16 $0 2.27% 26 $27 $0 1.37% $27 $0 1.37% NA NA NA $32 $1 2.33% TC ICM Interrogation in person NA NA NA $10 $0 3.85% 26 $22 $0 1.67% $22 $0 1.67% NA NA NA $33 $1 3.37% TC Wearable defib Interrogation in person NA NA NA $11 $0 3.33% 26 $22 $1 3.39% $22 $1 3.39% NA NA NA $28 $0 1.32% TC PM Peri‐px eval and programming NA NA NA $12 $0 3.03% 26 $15 $0 0.00% $15 $0 0.00% NA NA NA $37 $1 2.00% TC ICD Peri‐px eval and programming NA NA NA $13 $0 2.78% 26 $23 $0 1.56% $23 $0 1.56% NA NA NA $54 $0 0.67% TC TTM rhythm strip pacemaker eval NA NA NA $38 $0 0.95% 26 $16 $0 0.00% $16 $0 0.00% Wearable defib mobile telemetry w/phy r&I w/report 93294 PM Remote Interrogation 90 days all lead config 93295 ICD Remote interrogation 90 days all lead config 93296 PE‐ Remote data aquisition PM or ICD 93297 ICM Remote interrogation eval 30 days 93298 ILR Remote interrogation eval 30 days 93299 ICM and ILR Remote interr 30 days, tech Diagnostic Catheterization 93462 L hrt cath trnsptl puncture $27 $0 0.00% $27 $0 0.00% $34 $68 NA $27 $27 $0 $0 $0 NA $0 $0 $0 1.05% 0.53% NA 1.35% 0.00% NA $34 $68 $26 $27 $27 $0 $0 $0 $0 $0 $0 $0 1.05% 0.53% 1.39% 1.35% 0.00% NA $214 ($0) ‐0.17% $214 ($0) ‐0.17% See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 24 CPT® Modifier 93609 26 Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % Intraventricular and/or intra‐atrial mapping of tachycardia site(s) with catheter manipulation to record from multiple sites to identify origin of tachycardia (add on) $290 $4 1.25% $290 $4 1.25% 93613 Intracardiac electrophysiologic 3‐dimensional mapping (add on) $408 $5 1.33% NA NA NA 93619 26 Comprehensive electrophysiologic evaluation with right atrial pacing and recording, right ventricular pacing and recording, HIS bundle recording, including insertion and repositioning of multiple electrode catheters, without induction or attempted induction of arrhythmia $423 $4 0.85% $423 $4 0.85% 93620 26 Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of arrhythmia; with right atrial pacing and recording, right ventricular pacing and recording, His bundle recording $671 $5 0.75% $671 $5 0.75% 93621 26 93622 26 93623 26 with left atrial pacing and recording from coronary sinus or left atrium (add on) with left ventricular pacing and recording (add on) Programmed stimulation and pacing after intravenous drug infusion (add on) $122 $1 1.19% $122 $1 1.19% $178 $1 0.61% $178 $1 0.61% $166 $2 1.09% $166 $2 1.09% 93650 Intracardiac catheter ablation of atrioventricular node function, atrioventricular conduction for creation of complete heart block, with or without temporary pacemaker placement $622 $6 1.05% NA NA NA 93653 Comprehensive electrophysiologic evaluation including insertion and repositioning of multiple electrode catheters with induction or attempted induction of an arrhythmia with right atrial pacing and recording, right ventricular pacing and recording, HIS recording, with intracardiac catheter ablation of arrhythmogenic focus; with treatment of supraventiricular tachycardia by ablation of fast or slow atrioventricular pathyway, accessory atrioventricular connection, cavo‐tricuspid isthmus or other single atrial focus or source of atrial re‐entry. $874 $9 1.04% NA NA NA 93654 with treatment of ventricular tachycardia or focus of ventricular ectopy including intracardiac electrophysiologic 3D mapping, when performed, and left ventricular pacing and recording, when performed $1,163 $11 0.93% NA NA NA 93655 Intracardiac catheter ablation of a descrete mechanism of arrhythmia which is distinct from the primary ablated mechanism, including repeat diagnostic maneuvers, to treat a spontaneous or induced arrhythmia (add on) $437 $4 0.99% NA NA NA See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 25 Modifier CPT® Note: Rates subject to change and do NOT reflect the 20.1% SGR reduction expected to be addressed by Congress 2015 Variance 2015 Variance 2015 2015 Proposed Proposed vs. Proposed In‐ Proposed vs. Abbreviated (Partial) Description In‐Office 2014 Final 2014 Final Facility Rate Rate $ $ % $ $ % 93656 Comprehensive electrophysiologic evaluation including transseptal catheterizations, insertion and repositioning of multiple electrode catheters with induction or attempted induction of an arrhythmia with atrial recording and pacing, when possible, right ventricular pacing and recording, HIS bundle recording with intracardiac catheter ablation of arrhytmogenic focus, with treatment of atrial fibrillation by ablation by pulmonary vein isolation 93657 Additional linear or focal intracardiac catheter ablation of the left or right atrium for treatment of atrial fibrillation remaining after completion of pulmonary vein isolation (add on) $1,168 $14 1.24% NA NA NA $436 $4 0.83% NA NA NA $1 0.73% $148 $1 0.73% Intracardiac echocardiography during therapeutic/diagnostic $148 intervention, including imaging supervision and interpretation (add on) BSC currently has no FDA‐approved ablation catheters for the treatment of atrial fibrillation 93662 26 Common Procedural Terminology (CPT) copyright 2013 American Medical Association. All rights reserved. Important Information‐‐Please Note: • Please note: this coding information may include some codes for procedures for which Boston Scientific currently offers no cleared or approved products. In those instances, such codes have been included solely in the interest of providing users with comprehensive coding information and are not intended to promote the use of any Boston Scientific products for which they are not cleared or approved. • National average final base payment amounts. Specific payment rates may change due to geographic wage differences. • Payer policies will vary and should be verified prior to treatment for limitations on diagnosis, coding or site of service requirements. The coding options listed within this guide are commonly used codes and are not intended to be an all‐inclusive list. We recommend consulting your relevant manuals for appropriate coding options. See page 6 and 26 for important information about the uses and limitations of this document. Copyright © 2014 by Boston Scientific Corporation or its affiliates. All rights reserved. CRV-171008-AB JUL2014 26
© Copyright 2024